The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination.

Abstract

Biseugenol (Eug) is known to antiproliferative of cancer cells; however, to date, the antiperitoneal dissemination effects have not been studied in any mouse cancer model. In this study, Aryl hydrocarbon receptor (AhR) expression was associated with lymph node and distant metastasis in patients with gastric cancer and was correlated with clinicolpathological pattern. We evaluated the antiperitoneal dissemination potential of knockdown AhR and Biseugenol in cancer mouse model and assessed mesenchymal characteristics. Our results demonstrate that tumor growth, peritoneal dissemination and peritoneum or organ metastasis implanted MKN45 cells were significantly decreased in shAhR and Biseugenol-treated mice and that endoplasmic reticulum (ER) stress was caused. Biseugenol-exposure tumors showed acquired epithelial features such as phosphorylation of E-cadherin, cytokeratin-18 and loss mesenchymal signature Snail, but not vimentin regulation. Snail expression, through AhR activation, is an epithelial-to-mesenchymal transition (EMT) determinant. Moreover, Biseugenol enhanced Calpain-10 (Calp-10) and AhR interaction results in Snail downregulation. The effect of shCalpain-10 in cancer cells was associated with inactivation of AhR/Snail promoter binding activity. Inhibition of Calpain-10 in gastric cancer cells by short hairpin RNA or pharmacological inhibitor was found to effectively reduced growth ability and vessel density in vivo. Importantly, knockdown of AhR completed abrogated peritoneal dissemination. Herein, Biseugenol targeting ER stress provokes Calpain-10 activity, sequentially induces reversal of EMT and apoptosis via AhR may involve the paralleling processes. Taken together, these data suggest that Calpain-10 activation and AhR inhibition by Biseugenol impedes both gastric tumor growth and peritoneal dissemination by inducing ER stress and inhibiting EMT.

• Authors: De-Wei Lai, Shing-Hwa Liu, Anna Isabella Karlsson, Wen-Jane Lee, Keh-Bin Wang, Yi-Ching Chen, Chin-Chang Shen, Sheng-Mao Wu, Chia-Yu Liu, Hsing-Ru Tien, Yen-Chun Peng, Yee-Jee Jan, Te-Hsin Chao, Keng-Hsin Lan, Jack L Arbiser, Meei-Ling Sheu
• Journal: Oncotarget (Oncotarget) Vol. 5 Issue 17 Pg. 7788-804 (Sep 15 2014) ISSN: 1949-2553 [Electronic] United States
• PMID: 25226618 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents
• Receptors, Aryl Hydrocarbon

Topics

• Adenocarcinoma (pathology)
• Aged
• Animals
• Antineoplastic Agents (pharmacology)
• Chromatin Immunoprecipitation
• Disease Models, Animal
• Electrophoretic Mobility Shift Assay
• Endoplasmic Reticulum Stress (drug effects)
• Epithelial-Mesenchymal Transition (drug effects)
• Female
• Fluorescent Antibody Technique
• Humans
• Immunoblotting
• Immunoprecipitation
• Male
• Mice
• Microscopy, Confocal
• Microscopy, Electron, Transmission
• Middle Aged
• Peritoneal Neoplasms (secondary)
• Receptors, Aryl Hydrocarbon (antagonists & inhibitors, biosynthesis)
• Stomach Neoplasms (pathology)
• Xenograft Model Antitumor Assays